Sonic Healthcare Ltd's stock surged 6.73% during intraday trading on Thursday, reflecting significant investor optimism.
The sharp rise follows the company's release of its half-year results for the period ending December 31, 2025, which included H1 revenue of AUD 5,445 million and net income of AUD 262.5 million. Additionally, the company declared an interim dividend of 45 Australian cents per share, signaling strong financial health and a commitment to returning value to shareholders.
Investor sentiment was further bolstered by the CEO's presentation of the half-year results and news that an operating review of the US business is underway, indicating proactive management and potential for future growth in a key market.